Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion type Assertion NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_head.
- NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_provenance.
- NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion evidence source_evidence_literature NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_provenance.
- NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion SIO_000772 12835728 NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_provenance.
- NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion wasDerivedFrom befree-20140225 NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_provenance.
- NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion wasGeneratedBy ECO_0000203 NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_provenance.